Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4036656

N#Cc1c(C(N)=O)c2n(c1-c1cccnc1)CCNC2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 3/20 0.36
MKNK2 Q9HBH9 3/20 0.36
CSNK1D P48730 2/20 0.35
CSNK1E P49674 2/20 0.35
DPP4 P27487 1/20 0.35
DPP7 Q9UHL4 1/20 0.35
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
KDM4E B2RXH2 2/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP11B2 P19099 2/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
CYP11B1 P15538 1/20 0.34
PTGS2 P35354 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
GBA1 P04062 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4042312 0.90 HTR2A (0.40) CSNK1EHTR2AHTR2C
Trifluoroacetic Acid SCHEMBL4039701 0.85 CYP11B2 (0.33) HTR2AHTR2CCYP11B2CYP11B1
Trifluoroacetic Acid SCHEMBL4043668 0.83 MKNK1 (0.34) MKNK1MKNK2CSNK1DCSNK1EDPP4
Trifluoroacetic Acid SCHEMBL4036958 0.81 MKNK1 (0.36) MKNK1MKNK2CSNK1DCSNK1EDPP4
SCHEMBL4040261 0.79 MKNK1 (0.42) MKNK1MKNK2CSNK1DCSNK1EHTR2A
SCHEMBL7954819 0.78 KDM4E (0.42) MKNK1MKNK2CSNK1DCSNK1EKDM4E
Trifluoroacetic Acid SCHEMBL4039390 0.77 HTR2A (0.32) HTR2AHTR2C
Trifluoroacetic Acid SCHEMBL4036264 0.75 HTR2A (0.40) CSNK1EHTR2AHTR2C
SCHEMBL4047712 0.75 MKNK1 (0.38) MKNK1MKNK2CSNK1DCSNK1EHTR2A
Trifluoroacetic Acid SCHEMBL4038370 0.74 CSNK1E (0.36) CSNK1DCSNK1EHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1463728-B1 FUSED CYCLIC MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL MYERS SQUIBB CO (US) 2009-01-14 EP disclosed
EP-1436291-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS Aventis Pharma S.A. (FR) 2004-07-14 EP disclosed
WO-2003024967-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS AVENTIS PHARMA S.A. (FR) 2003-03-27 WO disclosed